Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review.

Hann KEJ, Freeman M, Fraser L, Waller J, Sanderson SC, Rahman B, Side L, Gessler S, Lanceley A; PROMISE study team.

BMC Public Health. 2017 May 25;17(1):503. doi: 10.1186/s12889-017-4375-8.

2.

Genomic Disparities in Breast Cancer Among Latinas.

Lynce F, Graves KD, Jandorf L, Ricker C, Castro E, Moreno L, Augusto B, Fejerman L, Vadaparampil ST.

Cancer Control. 2016 Oct;23(4):359-372.

3.

Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status.

Haas JS, Hill DA, Wellman RD, Hubbard RA, Lee CI, Wernli KJ, Stout NK, Tosteson AN, Henderson LM, Alford-Teaster JA, Onega TL.

Cancer. 2016 Feb 15;122(4):611-7. doi: 10.1002/cncr.29805. Epub 2015 Dec 28.

4.

Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial.

Livaudais-Toman J, Karliner LS, Tice JA, Kerlikowske K, Gregorich S, Pérez-Stable EJ, Pasick RJ, Chen A, Quinn J, Kaplan CP.

Breast. 2015 Dec;24(6):758-66. doi: 10.1016/j.breast.2015.09.009. Epub 2015 Oct 21.

5.

Why Breast Cancer Risk by the Numbers Is Not Enough: Evaluation of a Decision Aid in Multi-Ethnic, Low-Numerate Women.

Kukafka R, Yi H, Xiao T, Thomas P, Aguirre A, Smalletz C, David R, Crew K.

J Med Internet Res. 2015 Jul 14;17(7):e165. doi: 10.2196/jmir.4028.

6.

What Matters to Women When Making Decisions About Breast Cancer Chemoprevention?

Martinez KA, Fagerlin A, Witteman HO, Holmberg C, Hawley ST.

Patient. 2016 Apr;9(2):149-59. doi: 10.1007/s40271-015-0134-z.

7.

Hereditary cancer syndromes: opportunities and challenges.

Ashton-Prolla P.

BMC Proc. 2013 Apr 4;7 Suppl 2:K14. doi: 10.1186/1753-6561-7-S2-K14. eCollection 2013. No abstract available.

8.

A randomized, controlled trial to increase discussion of breast cancer in primary care.

Kaplan CP, Livaudais-Toman J, Tice JA, Kerlikowske K, Gregorich SE, Pérez-Stable EJ, Pasick RJ, Chen A, Quinn J, Karliner LS.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1245-53. doi: 10.1158/1055-9965.EPI-13-1380. Epub 2014 Apr 24.

9.

Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic.

Donnelly LS, Evans DG, Wiseman J, Fox J, Greenhalgh R, Affen J, Juraskova I, Stavrinos P, Dawe S, Cuzick J, Howell A.

Br J Cancer. 2014 Apr 2;110(7):1681-7. doi: 10.1038/bjc.2014.109. Epub 2014 Mar 4.

10.

Awareness of breast cancer among adolescent girls in Colombo, Sri Lanka: a school based study.

Ranasinghe HM, Ranasinghe N, Rodrigo C, Seneviratne Rde A, Rajapakse S.

BMC Public Health. 2013 Dec 20;13:1209. doi: 10.1186/1471-2458-13-1209.

11.

Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention.

Korfage IJ, Fuhrel-Forbis A, Ubel PA, Zikmund-Fisher BJ, Greene SM, McClure JB, Smith DM, Alford SH, Fagerlin A.

Breast Cancer Res. 2013;15(5):R74.

12.

A community cohort study about childhood social and economic circumstances: racial/ethnic differences and associations with educational attainment and health of older adults.

Yen IH, Gregorich S, Cohen AK, Stewart A.

BMJ Open. 2013 Apr 5;3(4). pii: e002140. doi: 10.1136/bmjopen-2012-002140. Print 2013.

13.

Choices for young women at intermediate risk of breast cancer.

Iqbal J, Narod SA.

Curr Oncol. 2012 Jun;19(3):e112-4. doi: 10.3747/co.19.925. No abstract available.

14.

The influence of health care policies and health care system distrust on willingness to undergo genetic testing.

Armstrong K, Putt M, Halbert CH, Grande D, Schwartz JS, Liao K, Marcus N, Demeter MB, Shea J.

Med Care. 2012 May;50(5):381-7. doi: 10.1097/MLR.0b013e31824d748b.

15.

Willingness to use tamoxifen to prevent breast cancer among diverse women.

Kaplan CP, Kim SE, Wong ST, Sawaya GF, Walsh JM, Pérez-Stable EJ.

Breast Cancer Res Treat. 2012 May;133(1):357-66. doi: 10.1007/s10549-012-1960-5.

16.

Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis.

Ropka ME, Keim J, Philbrick JT.

J Clin Oncol. 2010 Jun 20;28(18):3090-5. doi: 10.1200/JCO.2009.27.8077. Epub 2010 May 10. Review.

17.

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, Garber J, Vogel VG, Wade JL, Brown P, Cuzick J, Kramer BS, Lippman SM; American Society of Clinical Oncology.

J Clin Oncol. 2009 Jul 1;27(19):3235-58. doi: 10.1200/JCO.2008.20.5179. Epub 2009 May 26.

18.

Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk.

Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, Vogel V, Shepherd J, Vachon C, Smith-Bindman R, Kerlikowske K.

J Natl Cancer Inst. 2009 Mar 18;101(6):384-98. doi: 10.1093/jnci/djp018. Epub 2009 Mar 10. Review.

19.

Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers.

Bradbury AR, Ibe CN, Dignam JJ, Cummings SA, Verp M, White MA, Artioli G, Dudlicek L, Olopade OI.

Genet Med. 2008 Mar;10(3):161-166. doi: 10.1097/GIM.0b013e318163487d.

20.

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.

Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K.

Ann Intern Med. 2008 Mar 4;148(5):337-47.

Supplemental Content

Support Center